Bavarian Nordic reports Phase III data for smallpox vaccine
Jynneos vaccine has been assessed in a comprehensive development programme of 22 clinical trials. Credit: Bavarian Nordic.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more